SCHEMBL30837802

SCHEMBL30837802

CSc1ccc(Cn2c(=O)c3cc(OC(CF)CF)ccc3n(C3CCN(C=O)CC3)c2=O)cc1

nearest known ligand 0.76

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 10/20 0.76
PDE7B Q9NP56 5/20 0.76
PDE8A O60658 3/20 0.76
NPSR1 Q6W5P4 2/20 0.35
TSHR P16473 1/20 0.35
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
OPRL1 P41146 3/20 0.34
OPRM1 P35372 2/20 0.34
C5AR1 P21730 1/20 0.33
PRKDC P78527 1/20 0.33
TP53 P04637 1/20 0.33
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.33
OPRD1 P41143 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL100770 1.00 PDE7A (0.76) PDE7APDE7BPDE8ANPSR1TSHR
SCHEMBL100125 0.91 PDE7A (0.85) PDE7APDE7BPDE8ACYP3A4CYP2D6
SCHEMBL100797 0.91 PDE7A (0.72) PDE7APDE7BPDE8ANPSR1TSHR
SCHEMBL100794 0.90 PDE7A (0.78) PDE7APDE7BPDE8ANPSR1TSHR
SCHEMBL100681 0.90 PDE7A (0.78) PDE7APDE7BPDE8ANPSR1TSHR
SCHEMBL100985 0.89 PDE7A (0.77) PDE7APDE7BPDE8ANPSR1TSHR
SCHEMBL101060 0.89 PDE7A (0.77) PDE7APDE7BPDE8ANPSR1TSHR
SCHEMBL100825 0.89 PDE7A (0.76) PDE7APDE7BPDE8ANPSR1TSHR
SCHEMBL100959 0.89 PDE7A (0.76) PDE7APDE7BPDE8ANPSR1TSHR
SCHEMBL99919 0.89 PDE7A (0.78) PDE7APDE7BPDE8ANPSR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4572765-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE Mitodicure GmbH (DE) 2025-06-25 EP disclosed
WO-2024038089-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE MITODICURE GMBH (DE) 2024-02-22 WO disclosed